(EXEL) Exelixis - Performance 59.1% in 12m
Compare EXEL with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
37.24%
#16 in Group
Rel. Strength
91.83%
#657 in Universe
Total Return 12m
59.07%
#28 in Group
Total Return 5y
36.76%
#28 in Group
P/E 20.6
64th Percentile in Group
P/E Forward 16.5
71th Percentile in Group
PEG 2.27
88th Percentile in Group
FCF Yield 7.20%
94th Percentile in Group
12m Total Return: EXEL (59.1%) vs XBI (-2.3%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
-8% | 23.5% | 161% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
2.55% | 23.2% | 41.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
| AMGN NASDAQ Amgen |
-8.48% | 7.43% | 35.1% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
| LONN SW Lonza |
0.56% | 12.5% | 38.1% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
| BIM PA Biomerieux |
-1.7% | 17.1% | 0.22% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
-8.13% | -22.5% | 4.98% | 30.8 | 20.4 | 0.27 | 61.5% | 31.6% |
| KMDA NASDAQ Kamada |
-5.51% | 32.3% | -8.24% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
| ERF PA Eurofins Scientific SE |
6.82% | -5.27% | 21% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
Performance Comparison: EXEL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for EXEL
| Total Return (including Dividends) | EXEL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -0.74% | -7.84% | -4.31% |
| 3 Months | 14.36% | -13.34% | -7.85% |
| 12 Months | 59.07% | -2.25% | 10.76% |
| 5 Years | 36.76% | -18.04% | 106.31% |
| Trend Score (consistency of price movement) | EXEL | XBI | S&P 500 |
| 1 Month | 6.20% | -17.6% | -35.6% |
| 3 Months | 38.0% | -91.9% | -89.7% |
| 12 Months | 91.7% | -36.5% | 58.3% |
| 5 Years | 25.5% | -53.3% | 84.2% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #63 | 7.71% | 3.73% |
| 3 Month | #19 | 32.0% | 24.1% |
| 12 Month | #28 | 62.7% | 43.6% |
| 5 Years | #29 | 66.9% | -33.7% |
FAQs
Does EXEL Exelixis outperforms the market?
Yes,
over the last 12 months EXEL made 59.07%, while its related Sector, the SPDR S&P Biotech (XBI) made -2.25%.
Over the last 3 months EXEL made 14.36%, while XBI made -13.34%.
Over the last 3 months EXEL made 14.36%, while XBI made -13.34%.
Performance Comparison EXEL vs Indeces and Sectors
EXEL vs. Indices EXEL is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.98% | 3.57% | 38.6% | 48.3% |
| US NASDAQ 100 | QQQ | -3.94% | 3.50% | 38.6% | 47.1% |
| US Dow Jones Industrial 30 | DIA | 0.09% | 5.04% | 38.3% | 52.1% |
| German DAX 40 | DAX | 0.68% | 3.07% | 20.2% | 35.6% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 4.55% | 2.76% | 40.0% | 50.5% |
| Hongkong Hang Seng | HSI | 0.29% | 2.14% | 36.7% | 45.1% |
| India NIFTY 50 | INDA | 5.45% | -2.30% | 37.0% | 57.3% |
| Brasil Bovespa | EWZ | -1.73% | -2.71% | 34.1% | 64.6% |
EXEL vs. Sectors EXEL is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -1.84% | 4.84% | 29.9% | 36.7% |
| Consumer Discretionary | XLY | -4.33% | 3.30% | 35.4% | 44.7% |
| Consumer Staples | XLP | 5.48% | -3.49% | 33.3% | 49.6% |
| Energy | XLE | 1.37% | 10.9% | 41.0% | 71.0% |
| Financial | XLF | -0.02% | 4.04% | 30.5% | 39.8% |
| Health Care | XLV | 1.04% | 4.23% | 40.6% | 58.8% |
| Industrial | XLI | -0.15% | 3.33% | 38.3% | 52.2% |
| Materials | XLB | 1.27% | 3.77% | 45.5% | 64.4% |
| Real Estate | XLRE | 2.85% | 1.17% | 40.8% | 44.0% |
| Technology | XLK | -5.79% | 3.78% | 43.5% | 52.8% |
| Utilities | XLU | 2.17% | -2.42% | 35.5% | 38.6% |
| Aerospace & Defense | XAR | -1.54% | -0.44% | 27.3% | 32.1% |
| Biotech | XBI | -1.11% | 7.10% | 51.7% | 61.3% |
| Homebuilder | XHB | -0.23% | 5.28% | 53.6% | 67.0% |
| Retail | XRT | 0.81% | 2.19% | 42.7% | 62.7% |